Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Follitropin alfa
Drug ID BADD_D00954
Description Follitropin is a human follicle stimulating hormone (FSH) preparation of recombinant DNA origin, which consists of two non-covalently linked, non-identical glycoproteins designated as the alpha- and beta- subunits. The alpha- and beta- subunits have 92 and 111 amino acids. The alpha subunit is glycosylated at Asn 51 and Asn 78 while the beta subunit is glycosylated at Asn 7 and Asn 24. Follitropin beta is produced in genetically engineered Chinese hamster cell lines (CHO). The nomenclature “beta” differentiates it from another recombinant human FSH product that was marketed earlier as follitropin alpha. Follitropin is important in the development of follicles produced by the ovaries. Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF). Numerous physio-chemical tests and bioassays indicate that follitropin beta and follitropin alpha are indistinguishable. However, a more recent study showed there is may be a slight clinical difference, with the alpha form tending towards a higher pregnancy rate and the beta form tending towards a lower pregnancy rate, but with significantly higher estradiol (E2) levels. Structural analysis shows that the amino acid sequence of follitropin beta is identical to that of natural human follicle stimulating hormone (FSH). Further, the ogliosaccharide side chains are very similar, but not completely identical to that of natural FSH. However, these small differences do not affect the bioactivity compared to natural FSH.
Indications and Usage In women having been diagnosed with primary ovarian failure, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. In men with hypogonadotrophic hypogonadism, it is used to induce spermatogenesis. Follitropin may also be used to cause the ovary to produce several follicles, which can then be harvested for use in gamete intrafallopian transfer (GIFT) or in vitro fertilization (IVF).
Marketing Status Prescription; Discontinued
ATC Code G03GA05
DrugBank ID DB00066
KEGG ID D04429
MeSH ID C571801
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code 44087-9030; 44087-9005; 44087-9070
Synonyms follitropin alfa | Gonal F | Gonal-F
Chemical Information
Molecular Formula Not Available
CAS Registry Number 146479-72-3
SMILES Not Available
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Ovarian cyst16.04.03.001; 21.11.01.002--Not Available
Ovarian enlargement21.11.02.001--Not Available
Ovarian hyperstimulation syndrome21.11.02.007; 05.05.01.013--Not Available
Pain08.01.08.004--
Peritoneal haemorrhage24.07.02.016; 07.07.02.001--Not Available
Pharyngitis07.05.07.004; 22.07.03.004; 11.01.13.003--
Pollakiuria20.02.02.007--
Premature labour18.07.01.002--Not Available
Pyrexia08.05.02.003--
Rhinitis22.07.03.006; 11.01.13.004--
Sinusitis22.07.03.007; 11.01.13.005--
Toothache07.09.06.001--
Uterine haemorrhage24.07.03.004; 21.07.01.005--
Vaginal haemorrhage24.07.03.005; 21.08.01.001--
Viral infection11.05.04.001--Not Available
Hot flush21.02.02.001; 08.01.03.027; 24.03.01.005--
Pulmonary vascular disorder24.03.08.003; 22.06.03.002--Not Available
Ovarian neoplasm21.11.01.005; 16.12.06.001--Not Available
Genital pain21.10.01.008--Not Available
Adnexal torsion21.11.02.012--Not Available
The 2th Page    First    Pre   2    Total 2 Pages